Your browser doesn't support javascript.
loading
The Down syndrome brain in the presence and absence of fibrillar ß-amyloidosis.
Annus, Tiina; Wilson, Liam R; Acosta-Cabronero, Julio; Cardenas-Blanco, Arturo; Hong, Young T; Fryer, Tim D; Coles, Jonathan P; Menon, David K; Zaman, Shahid H; Holland, Anthony J; Nestor, Peter J.
Afiliação
  • Annus T; Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Douglas House, Cambridge, UK. Electronic address: t.annus@cantab.net.
  • Wilson LR; Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Douglas House, Cambridge, UK.
  • Acosta-Cabronero J; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany; Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK.
  • Cardenas-Blanco A; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Hong YT; Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Fryer TD; Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Coles JP; Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Menon DK; Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Zaman SH; Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Douglas House, Cambridge, UK; Cambridgeshire and Peterborough NHS Foundation Trust, Elizabeth House, Fulbourn Hospital, Fulbourn, Cambridge, UK.
  • Holland AJ; Cambridge Intellectual and Developmental Disabilities Research Group, Department of Psychiatry, University of Cambridge, Douglas House, Cambridge, UK; Cambridgeshire and Peterborough NHS Foundation Trust, Elizabeth House, Fulbourn Hospital, Fulbourn, Cambridge, UK.
  • Nestor PJ; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Neurobiol Aging ; 53: 11-19, 2017 05.
Article em En | MEDLINE | ID: mdl-28192686
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encefalopatias Metabólicas / Córtex Cerebral / Peptídeos beta-Amiloides / Síndrome de Down / Substância Cinzenta / Amiloidose Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neurobiol Aging Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encefalopatias Metabólicas / Córtex Cerebral / Peptídeos beta-Amiloides / Síndrome de Down / Substância Cinzenta / Amiloidose Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neurobiol Aging Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos